Cover Image
市場調查報告書

心臟再同步化治療 - 心臟去顫器 (CRT-D) :開發中產品分析

Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 358888
出版日期 內容資訊 英文 65 Pages
訂單完成後即時交付
價格
Back to Top
心臟再同步化治療 - 心臟去顫器 (CRT-D) :開發中產品分析 Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年06月01日 內容資訊: 英文 65 Pages
簡介

本報告提供目前開發中的心臟再同步化治療 - 心臟去顫器 (CRT-D) 之開發中產品資訊調查分析,提供您主要產品·計劃,主要企業,臨床實驗資訊,最近的趨勢等系統性資訊。

第1章 目錄

第2章 簡介

  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) 概要

第3章 開發中的產品

  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各開發階段
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各市場區隔
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各地區
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各法規途徑
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各核准時期 (預定)
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:進行中的臨床實驗

第4章 心臟再同步化治療 - 心臟去顫器 (CRT-D) :開發中的開發中產品 (各企業)

  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) 企業 - 開發中產品:各開發階段
  • 心臟再同步化治療 - 心臟去顫器 (CRT-D) - 開發中產品:各開發階段

第5章 心臟再同步化治療 - 心臟去顫器 (CRT-D) 企業與產品概要

  • Boston Scientific Corporation
  • John Hopkins University
  • LivaNova PLC
  • Medtronic plc
  • Sorin Group Italia S.r.l
  • St. Jude Medical, Inc.
  • TransWorld Med Corporation

第6章 心臟再同步化治療 - 心臟去顫器 (CRT-D) :最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0192EPD

GlobalData's Medical Devices sector report, "Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2016" provides an overview of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Overview

3. Products under Development

  • 3.1. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
  • 3.2. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
  • 3.3. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
  • 3.4. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
  • 3.5. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
  • 3.6. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials

4. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products under Development by Companies

  • 4.1. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development
  • 4.2. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development

5. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies and Product Overview

  • 5.1. Boston Scientific Corporation Company Overview
    • 5.1.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. John Hopkins University Company Overview
    • 5.2.1. John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. LivaNova PLC Company Overview
    • 5.3.1. LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Medtronic plc Company Overview
    • 5.4.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Sorin Group Italia S.r.l Company Overview
    • 5.5.1. Sorin Group Italia S.r.l Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. St. Jude Medical, Inc. Company Overview
    • 5.6.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. TransWorld Med Corporation Company Overview
    • 5.7.1. TransWorld Med Corporation Pipeline Products & Ongoing Clinical Trials Overview

6. Cardiac Resynchronisation Therapy - Defibrillators (CRT-D)- Recent Developments

  • 6.1. May 16, 2016: Heart Hospital of Austin First in Texas to Offer MultiPoint Pacing Technology for Heart Failure Patients
  • 6.2. May 05, 2016: SonR: 35% Risk Reduction in Heart Failure Hospitalization
  • 6.3. May 04, 2016: Overlake Becomes First Hospital in Washington to Offer MultiPoint Pacing Technology for Heart Failure Patients
  • 6.4. Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016
  • 6.5. Apr 26, 2016: Allied 100 Acquires Lifeguard Medical Solutions
  • 6.6. Apr 18, 2016: St. Jude Medical Announces Launch And First US Implants Of MultiPoint Pacing Technology
  • 6.7. Apr 13, 2016: Nihon Kohden Evolves Brand, Website to Meet Needs of Changing Healthcare Environment
  • 6.8. Apr 08, 2016: Lankenau Heart Institute at Paoli Hospital has Implanted the Region's First MRI-Safe Cardiac Resynchronization Defibrillator
  • 6.9. Apr 05, 2016: St. Jude Medical Announces MHLW Approval for MRI Conditional Labeling on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients
  • 6.10. Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors
  • 6.11. Feb 22, 2016: Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans
  • 6.12. Feb 05, 2016: Medtronic's Amplia MRI Quad CRT-D SureScan System Receives FDA Approval for Treatment of Heart Failure
  • 6.13. Feb 05, 2016: Medtronic's Compia MRI Quad CRT-D SureScan System Receives FDA Approval For Treatment Of Heart Failure
  • 6.14. Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015
  • 6.15. Feb 03, 2016: Nihon Kohden America Receives Great Place to Work Certification
  • 6.16. Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence
  • 6.17. Dec 10, 2015: BIOTRONIK Announces Start of New Study Evaluating whether Pacemakers with Closed Loop Stimulation Prevent Reflex Syncope
  • 6.18. Dec 02, 2015: St. Jude Medical Announces CE Mark for MRI Compatibility on Quadra Assura CRT-D to Improve Access to Diagnostic Imaging for Heart Failure Patients
  • 6.19. Dec 01, 2015: BIOTRONIK Announces Start of Study to Evaluate Benefits of Unique Rate Response Algorithm for Atrial Fibrillation Patients
  • 6.20. Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015
  • 6.21. Aug 25, 2015: BIOTRONIK presents its CRT-Ds Approved for Full-Body MRI Scanning at ESC Congress 2015
  • 6.22. Aug 24, 2015: Boston Scientific Announces CE Mark For MRI Compatible Labeling For ICD And CRT-D Systems
  • 6.23. Aug 05, 2015: BIOTRONIK Announces Start of First Study to Assess Relevance of Defibrillator Back-Up after CRT-D Replacement
  • 6.24. Jul 31, 2015: Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2016
  • 6.25. Jul 24, 2015: ZOLL Equips Toronto 2015 Pan American, Parapan American Games with Defibrillators
  • 6.26. Jul 24, 2015: ZOLL Equips Toronto 2015 Pan American, Parapan American Games with Defibrillators
  • 6.27. Jul 23, 2015: Boston Scientific Announces Results For Second Quarter 2015
  • 6.28. Jul 16, 2015: ZOLL Announces Release of Its CPR Extract Capability
  • 6.29. Jul 02, 2015: BIOTRONIK Announces Start of Pioneering BIOWOMEN Study
  • 6.30. Jun 22, 2015: Boston Scientific Begins EMBLEM Defibrillator Study In Sudden Cardiac Death
  • 6.31. Jun 16, 2015: Hill-Rom Acquires Welch Allyn for USD2.05 Billion

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
  • Table 2: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
  • Table 3: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
  • Table 4: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
  • Table 5: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
  • Table 6: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials
  • Table 7: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) Companies - Pipeline Products by Stage of Development
  • Table 8: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
  • Table 9: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Autogen X4 CRT-D - Product Status
  • Table 11: Autogen X4 CRT-D - Product Description
  • Table 12: Next Generation Quad Polar CRT-D - Product Status
  • Table 13: Next Generation Quad Polar CRT-D - Product Description
  • Table 14: NG3 Non Quad System - Product Status
  • Table 15: NG3 Non Quad System - Product Description
  • Table 16: Boston Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 17: Autogen X4 CRT-D - Capture Information Via Automatic Threshold Evaluation
  • Table 18: Autogen X4 CRT-D - Sleep-disordered Breathing in Patients with Implanted Cardiac Devices: Validation of the Apneascan Algorithm and Implications for Prognosis
  • Table 19: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Cardiac Arrhythmia Termination Device - Product Status
  • Table 21: Cardiac Arrhythmia Termination Device - Product Description
  • Table 22: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Paradym RF Platform - Product Status
  • Table 24: Paradym RF Platform - Product Description
  • Table 25: PARADYM RF SonR CRT-D - Product Status
  • Table 26: PARADYM RF SonR CRT-D - Product Description
  • Table 27: Platinium Brady - Product Status
  • Table 28: Platinium Brady - Product Description
  • Table 29: Platinium Tachy - Product Status
  • Table 30: Platinium Tachy - Product Description
  • Table 31: LivaNova PLC - Ongoing Clinical Trials Overview
  • Table 32: PARADYM RF SonR CRT-D - Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D
  • Table 33: PARADYM RF SonR CRT-D - First Implant Of A New-Generation CRT-D Device Designed To Provide Hemodynamic Management Of Heart Failure
  • Table 34: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: MRI Safe CRT-D - Product Status
  • Table 36: MRI Safe CRT-D - Product Description
  • Table 37: Sorin Group Italia S.r.l Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Paradym CRT-D Tri-V Device - Product Status
  • Table 39: Paradym CRT-D Tri-V Device - Product Description
  • Table 40: Sorin Group Italia S.r.l - Ongoing Clinical Trials Overview
  • Table 41: Paradym CRT-D Tri-V Device - SonR FIX Atrial Lead Multi-Centre Clinical Trial
  • Table 42: Paradym CRT-D Tri-V Device - Triple-site Biventricular Stimulation in the Optimization of Cardiac Resynchronization Therapy (CRT)
  • Table 43: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Quadra Assura MP CRT-D - Product Status
  • Table 45: Quadra Assura MP CRT-D - Product Description
  • Table 46: St. Jude Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 47: Quadra Assura MP CRT-D - Italian Registry on Multipoint Left Ventricular
  • Table 48: TransWorld Med Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Soul Mate - Defibrillator - Product Status
  • Table 50: Soul Mate - Defibrillator - Product Description
  • Table 51: Glossary

List of Figures

  • Figure 1: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Stage of Development
  • Figure 2: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Segment
  • Figure 3: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Territory
  • Figure 4: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Regulatory Path
  • Figure 5: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Pipeline Products by Estimated Approval Date
  • Figure 6: Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Ongoing Clinical Trials
Back to Top